Prognostic impact of young age on stage IV prostate cancer treated with primary androgen deprivation therapy-Reference-Cited by-同舟云学术

Prognostic impact of young age on stage IV prostate cancer treated with primary androgen deprivation therapy

Published:2014-01-09 Issue:6 Volume:21 Page:578-583
ISSN:0919-8172
Container-title:International Journal of Urology
language:en
Short-container-title:Int J Urol

Author:

Kimura Tomokazu¹,Onozawa Mizuki²,Miyazaki Jun¹,Matsuoka Taeko¹,Joraku Akira¹,Kawai Koji¹,Nishiyama Hiroyuki¹,Hinotsu Shiro³,Akaza Hideyuki⁴

Affiliation:

1. Department of Urology; Faculty of Medicine; University of Tsukuba; Tsukuba Japan

2. Department of Urology; Tokyo-kita Social Insurance Hospital; Tokyo Japan

3. Center for Innovative Clinical Medicine; Okayama University; Okayama Japan

4. Department of Strategic Investigation on Comprehensive Cancer Network; Research Center for Advanced Science and Technology; University of Tokyo; Tokyo Japan

Publisher

Wiley

Subject

Urology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/iju.12389/fullpdf

Reference29 articles.

1. Prostate cancer in men age 50 years or younger: a review of the Department of Defense Center for Prostate Disease Research multicenter prostate cancer database;Smith;J. Urol.,2000

2. Prostate cancer in men less than the age of 50: a comparison of race and outcomes;Parker;Urology,2011

3. Implications of stage-specific survival rates in assessing recent declines in prostate cancer mortality rates;Tarone;Epidemiology,2000

4. Contemporary role of androgen deprivation therapy for prostate cancer;Pagliarulo;Eur. Urol.,2012

5. EAU guidelines on prostate cancer;Heidenreich;Eur. Urol.,2008

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Outcomes in patients with high- and very high-risk localized prostate cancer treated with definitive IMRT and long-term hormone therapy;Japanese Journal of Clinical Oncology;2023-12-23

2. Outcome of 177Lu-PSMA-617 Radioligand Therapy in Chemo-Refractory Patients with Metastatic Castration-Resistant Early-Onset Prostate Cancer;Cancers;2021-08-20

3. Clinical outcomes and prognosis of metastatic prostate cancer patients ≤ 60-year-old;World Journal of Urology;2021-07-19

4. Dynamics of conditional survival and risk factors in androgen deprivation therapy for prostate cancer using a multi‐institutional Japan‐wide database;International Journal of Urology;2021-05-24

5. Increased risk of disease progression in younger men: Analysis of factors predicting biochemical failure and castration-resistant prostate cancer after high-dose intensity-modulated radiation therapy for nonmetastatic prostate cancer;Urologic Oncology: Seminars and Original Investigations;2021-02